Evaluation of Oral Hypo-osmolar Glucose-based and Rice-based Oral Rehydration Solutions in the Treatment of Cholera in Children
Overview
Authors
Affiliations
Unlabelled: In a randomized controlled clinical trial, the efficacy of a low-sodium low-glucose oral rehydration solution (ORS) and a low-sodium rice-based ORS was compared with standard WHO glucose ORS in the treatment of severe cholera in children aged 2-10y. In total, 120 children were evaluated for the study, of whom 58 patients were positive for Vibrio cholerae and were included in the study. Of these 58 cases, 19 received rice-based hypo-osmolar ORS, 20 received WHO-ORS and 19 received glucose-based hypo-osmolar ORS. The clinical characteristics (age, preadmission duration of diarrhoea, frequency of stool before admission, incidence of vomiting, body weight and volume of initial fluid requirement) were comparable in the three treatment groups. All patients received tetracycline in a dose of 50 mg/kg/d of body weight in 4 divided doses for 3 d.
Conclusions: Patients who received rice-based hypo-osmolar ORS had subsequently reduced (p < 0.05) stool output, ORS consumption and diarrhoea duration than the patients who received either WHO-ORS or glucose-based hypo-osmolar ORS.
Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT).
Nalin D Trop Med Infect Dis. 2021; 6(1).
PMID: 33809275 PMC: 8005945. DOI: 10.3390/tropicalmed6010034.
Polymer-based oral rehydration solution for treating acute watery diarrhoea.
Gregorio G, Gonzales M, Dans L, Martinez E Cochrane Database Syst Rev. 2016; 12:CD006519.
PMID: 27959472 PMC: 5450881. DOI: 10.1002/14651858.CD006519.pub3.
Kuhn J, Finger F, Bertuzzo E, Borgeaud S, Gatto M, Rinaldo A PLoS Negl Trop Dis. 2014; 8(12):e3347.
PMID: 25474211 PMC: 4256474. DOI: 10.1371/journal.pntd.0003347.
Oral rehydration therapy in the second decade of the twenty-first century.
Binder H, Brown I, Ramakrishna B, Young G Curr Gastroenterol Rep. 2014; 16(3):376.
PMID: 24562469 PMC: 3950600. DOI: 10.1007/s11894-014-0376-2.
Musekiwa A, Volmink J Cochrane Database Syst Rev. 2011; (12):CD003754.
PMID: 22161381 PMC: 6532622. DOI: 10.1002/14651858.CD003754.pub3.